A randomized phase 1b trial of the active site polymerase inhibitor nucleotide <scp>ATI</scp> ‐2173 in patients with chronic hepatitis B virus infection-Reference-Cited by-同舟云学术

A randomized phase 1b trial of the active site polymerase inhibitor nucleotide ATI ‐2173 in patients with chronic hepatitis B virus infection

Published:2022-10-22 Issue:1 Volume:30 Page:19-28
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:Journal of Viral Hepatitis

Author:

Squires Katherine E.¹^ORCID,Ogilvie Lauren¹,Jucov Alina²³,Anastasiy Igor³⁴,Ghicavii Nelli²,Huguet Jade⁵,Melara Rebeca⁵,Constantineau Martin⁵,De La Rosa Abel¹,Mayers Douglas L.¹

Affiliation:

1. Antios Therapeutics Doylestown Pennsylvania USA

2. ARENSIA Exploratory Medicine Republican Clinical Hospital Chisinau Moldova

3. Department of Infectious Diseases Nicolae Testemitanu State University of Medicine and Pharmacy Chisinau Moldova

4. ARENSIA Exploratory Medicine Kiev Ukraine

5. Altasciences, Montreal Quebec Canada

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13753

Reference36 articles.

1. Hepatitis B Foundation.Hepatitis B facts and figures. Accessed October 20 2021.https://www.hepb.org/what‐is‐hepatitis‐b/what‐is‐hepb/facts‐and‐figures/

2. Chronic Hepatitis B Infection

3. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

4. Chronic hepatitis B virus infection

5. Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cure

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspective on Emerging Therapies to Achieve Functional Cure of Chronic Hepatitis B;Current Hepatology Reports;2024-02-10

2. Hepatitis B Virus Epsilon (ε) RNA Element: Dynamic Regulator of Viral Replication and Attractive Therapeutic Target;Viruses;2023-09-12

3. Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure;Drugs;2023-03-11

4. Therapies against chronic hepatitis B infections: The times they are a-changin’, but the changing is slow!;Antiviral Research;2023-02

5. Active site polymerase inhibitor nucleotides (ASPINs): Potential agents for chronic HBV cure regimens;Antiviral Chemistry and Chemotherapy;2022-01